The Europe Electroencephalography Devices Market would witness market growth of 9.3% CAGR during the forecast period (2022-2028).
Cognitive health is defined as the ability to learn, think, and remember. Good cognitive health translates to better functioning of the brain. Functions like emotional responses, sensory responses, and motor skills imply resilience to neuropathological damage. Generally, the environmental, lifestyle and genetic constitution are regarded as the main factors that influence the cognitive health of a person.
Most controllable lifestyle and environmental factors include diseases and disorders that deteriorate the condition of the brain like diabetes, stroke, heart disease, depression, and traumatic brain injuries. The simultaneous actions like the use of certain medicines or their abuse or improper use, poor diet, smoking, and lack of physical activity have been stated to be the most prominent causes for increasing brain disorder incidences.
Other than these, alcoholism, sleep disorders, and little to no social activity also aggravate any underlying cognitive issues. An extremely common disorder called dementia occurs when the cognitive function of the brain has deteriorated beyond the usual limits of biological aging. This disorder results from numerous injuries and diseases that primarily or secondarily affected the functioning of the brain. Dementia also has a psychological, social, physical, and economic impact that affects both, the patient and their caretakers.
Epilepsy Advocacy Europe (EAE) started the European Forum on Epilepsy Research (ERF2013) with International Bureau for Epilepsy (IBE) and International League Against Epilepsy (ILAE). The 7th Framework Program co-funded this forum and was jointly hosted during the European Month of the Brain. This allowed propagating the Written Declaration on Epilepsy, which was accepted by the European Parliament in 2011. Europe has almost 6 million citizens suffering from epilepsy, as recognized by the declaration. Many of these face problems at school and face high levels of prejudice, unemployment, and stigma.
The Germany market dominated the Europe Electroencephalography Devices Market by Country in 2021; thereby, achieving a market value of $116.5 million by 2028. The UK market is exhibiting a CAGR of 8.3% during (2022 - 2028). Additionally, The France market would experience a CAGR of 10.1% during (2022 - 2028).
Based on Type, the market is segmented into Standalone and Portable. Based on End User, the market is segmented into Hospitals, Diagnostic Centers and Others. Based on Product, the market is segmented into 32-channel, 25-channel, 40-channel, 21-channel, 8-channel and Multichannel. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Electroencephalography Devices Market will Hit $1.8 Billion by 2028, at a CAGR of 9.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Compumedics Limited, Natus Medical Incorporated (Archimed SAS), Nihon Kohden Corporation, Cadwell Industries, Inc., Neurowave Systems, Inc., Magstim EGI (Magstim, Inc.) and Noraxon U.S.A., Inc.
By Type
By End User
By Product
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
